Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 8/20 | 0.90 |
| ▸ | MEN1 | O00255 | 1/20 | 0.90 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.90 |
| ▸ | RARA | P10276 | 1/20 | 0.90 |
| ▸ | MAPT | P10636 | 1/20 | 0.90 |
| ▸ | MTOR | P42345 | 1/20 | 0.90 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.90 |
| ▸ | THRA | P10827 | 2/20 | 0.67 |
| ▸ | THRB | P10828 | 2/20 | 0.67 |
| ▸ | ATG4B | Q9Y4P1 | 7/20 | 0.66 |
| ▸ | PLA2G1B | P04054 | 6/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8080374 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL82569 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL2185929 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL970162 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL270423 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL503648 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL18979350 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL503506 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL18979307 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL980560 | 1.00 | RARB (0.90) | RARBMEN1ALDH1A1RARAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692041-A1 | METHOD FOR PRODUCING BIO-DERIVED ESTER COMPOUND, BIO-DERIVED ESTER COMPOUND PRODUCED THEREBY, COSMETIC OR DETERGENT CONTAINING BIO-DERIVED ESTER COMPOUND, AND METHOD FOR REDUCING ODOR OF ESTER COMPOUND | ADEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024204392-A1 | METHOD FOR PRODUCING BIO-DERIVED ESTER COMPOUND, BIO-DERIVED ESTER COMPOUND PRODUCED THEREBY, COSMETIC OR DETERGENT CONTAINING BIO-DERIVED ESTER COMPOUND, AND METHOD FOR REDUCING ODOR OF ESTER COMPOUND | 株式会社ADEKA | 2024-10-03 | — | — | WO | disclosed |
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2018-08-02 | — | — | US | disclosed |
| US-9908849-B2 | Imidamide sphingosine kinase inhibitors | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2018-03-06 | — | — | US | disclosed |
| EP-3181569-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME | UBE Industries, Ltd. (JP) | 2017-06-21 | — | — | EP | disclosed |
| US-20170166525-A1 | IMIDAMIDE SPHINGOSINE KINASE INHIBITORS | UNIVERSITY OF VIRGINIA | 2017-06-15 | — | — | US | disclosed |
| US-9421177-B2 | Imidamide sphingosine kinase inhibitors | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2016-08-23 | — | — | US | disclosed |
| CN-101811981-B | Small-angle inverted V-shaped long lateral-chain ferroelectric liquid crystal compound and synthesis method thereof | UNIV BEIHANG | 2013-06-26 | — | — | CN | disclosed |
| US-20120214858-A1 | IMIDAMIDE SPHINGOSINE KINASE INHIBITORS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2012-08-23 | — | — | US | disclosed |
| WO-2011020116-A1 | IMIDAMIDE SPHINGOSINE KINASE INHIBITORS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2011-02-17 | — | — | WO | disclosed |
| CN-101811981-A | Small-angle inverted V-shaped long lateral-chain ferroelectric liquid crystal compound and synthesis method thereof | UNIV BEIHANG | 2010-08-25 | — | — | CN | disclosed |
| EP-0758013-B1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL CO LTD (JP) | 2000-10-11 | — | — | EP | disclosed |
| US-5855971-A | Liquid crystalline optical film, compensating film for liquid crystal display comprising the liquid crystalline optical film, and liquid crystal display having the compensating film | NIPPON OIL COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0758013-A1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL COMPANY, LIMITED (JP) | 1997-02-12 | — | — | EP | disclosed |
| US-4774342-A | ANTITUMOR AGENTS | SUNTORY LIMITED (JP) | 1988-09-27 | — | — | US | disclosed |
| US-4556495-A | INJECTING AN ALKALI METAL CARBOXYLATE, POLAR COSURFACTANT, ELECTROLYTE | PHILLIPS PETROLEUM COMPANY (US) | 1985-12-03 | — | — | US | disclosed |
| EP-0108645-A2 | Novel ailanthone derivative | SUNTORY LIMITED (JP) | 1984-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | IKZF3, HELZ, TEC | RARB 695/4885MEN1 3053/4885ALDH1A1 246/4885 |
| US-20120214858-A1 | IMIDAMIDE SPHINGOSINE KINASE INHIBITORS | SPHK2, SPHK1, S1PR2 | RARB 4533/4885MEN1 1068/4885ALDH1A1 4570/4885 |
| US-20170166525-A1 | IMIDAMIDE SPHINGOSINE KINASE INHIBITORS | SPHK2, SPHK1, S1PR2 | RARB 4533/4885MEN1 1068/4885ALDH1A1 4570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.